1.Effects of 12 months of continuous positive airway pressure therapy on cognitive function, sleep, mood, and health-related quality of life in a peritoneal dialysis patient with obstructive sleep apnea.
Kyoung Sook PARK ; Jung Hyun CHANG ; Ea Wha KANG
Kidney Research and Clinical Practice 2018;37(1):89-93
This report describes the case of a hypertensive 51-year-old male with a 3-year history of peritoneal dialysis. We followed the patient through his diagnosis of severe obstructive sleep apnea (OSA) and treatment with continuous positive airway pressure (CPAP). Therapeutic use of CPAP led to the improvement of not only sleep-related problems, but also cognitive function and quality of life. To our knowledge, this is the first paper describing the benefits of long-term CPAP treatment in an OSA patient undergoing dialysis. This case report emphasizes the need for the proactive diagnosis and treatment of OSA in end-stage renal disease patients to improve patient-centered healthcare.
Cognition*
;
Continuous Positive Airway Pressure*
;
Delivery of Health Care
;
Diagnosis
;
Dialysis
;
Humans
;
Kidney Failure, Chronic
;
Male
;
Middle Aged
;
Peritoneal Dialysis*
;
Quality of Life*
;
Sleep Apnea, Obstructive*
2.A Case of AA Amyloidosis Treated with Infliximab.
Da Ham KIM ; Kyeong Hye PARK ; Su Hwan LEE ; Shin Young HYUN ; Jeong Hae KIE ; Ea Wha KANG
Korean Journal of Nephrology 2010;29(5):638-643
AA amyloidosis is one of the most significant complications of rheumatoid arthritis characterized by the deposition of amyloid A (AA) in multiple organs and tissues in the body. This disorder displays variable clinical symptoms depending upon the involved organ and a diagnosis is rendered through a biopsy of the affected organ, followed by staining using Congo-red which reveals an apple-green birefringence. Fundamental disease control is critical in the treatment of AA amyloidosis. Anti-tumor necrosis factor alpha (anti TNF-alpha) agents are promising in inducing clinical remission by suppressing systemic inflammation in AA amyloidosis. We report a case of AA amyloidosis in a 71 year old woman with rheumatoid arthritis that responded well to infliximab therapy.
Amyloid
;
Amyloidosis
;
Antibodies, Monoclonal
;
Arthritis, Rheumatoid
;
Biopsy
;
Birefringence
;
Female
;
Humans
;
Inflammation
;
Necrosis
;
Infliximab
3.Bilateral Anterior Ischemic Optic Neuropathy with Sudden Sensorineural Hearing Loss in a Long term Hemodialysis Patient.
Jeong Kyung PARK ; Min Keun SONG ; Sun Hye KIM ; Hye Young KIM ; Su Jin HAN ; Ea Wha KANG
Korean Journal of Nephrology 2008;27(3):397-401
Anterior ischemic optic neuropathy (AION) is rarely reported in end stage renal disease. In particular, AION combined with sudden sensorineural hearing loss (SNHL) has not been reported in domestic and international journals. Here we report the first case of this combined condition. A 58-year-old male patient in end-stage renal disease presented on painless bilateral visual and hearing deterioration. Clinical findings and imaging studies were compatible with a diagnosis of AION and SNHL. Despite of high-dose steroid therapy, vision and hearing were not significantly recovered. Uremic patients often have coexisting pathology such as hypotension during dialysis, atherosclerosis and anemia, predisposing to AION and SNHL. We describe a patient of dialysis for 10 years who presented with bilateral visual and hearing loss due to complications of long-term dialysis. Our case suggests that nephrologists have to know and treat more carefully this rare but emergent complications of dialysis.
Anemia
;
Atherosclerosis
;
Dialysis
;
Hearing
;
Hearing Loss
;
Hearing Loss, Sensorineural
;
Humans
;
Hypotension
;
Kidney Failure, Chronic
;
Male
;
Middle Aged
;
Optic Neuropathy, Ischemic
;
Renal Dialysis
;
Vision, Ocular
4.Vaccine Effect on Household Transmission of Omicron and Delta SARS-CoV-2 Variants
Yong Chan KIM ; Bongyoung KIM ; Nak-Hoon SON ; Namwoo HEO ; Yooju NAM ; Areum SHIN ; Andrew Jihoon YANG ; Min Hyung KIM ; Taeyoung KYONG ; Eawha KANG ; Yoon Soo PARK ; Heejung KIM
Journal of Korean Medical Science 2023;38(1):e9-
Background:
We evaluated the household secondary attack rate (SAR) of the omicron and delta severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, according to the vaccination status of the index case and household contacts; further, in vaccinated index cases, we evaluated the effect of the antibody levels on household transmission.
Methods:
A prospective cross-sectional study of 92 index cases and 197 quarantined household contacts was performed. Tests for SARS-CoV-2 variant type and antibody level were conducted in index cases, and results of polymerase chain reaction tests (during the quarantine period) were collected from contacts. Association of antibody levels in vaccinated index cases and SAR was evaluated by multivariate regression analysis.
Results:
The SAR was higher in households exposed to omicron variant (42%) than in those exposed to delta variant (27%) (P = 0.040). SAR was 35% and 23% for unvaccinated and vaccinated delta variant exposed contacts, respectively. SAR was 44% and 41% for unvaccinated and vaccinated omicron exposed contacts, respectively. Booster dose immunisation of contacts or vaccination of index cases reduced SAR of vaccinated omicron variant exposed contacts. In a model with adjustment, anti-receptor-binding domain antibody levels in vaccinated index cases were inversely correlated with household transmission of both delta and omicron variants.Neutralising antibody levels had a similar relationship.
Conclusion
Immunisation of household members may help to mitigate the current pandemic.